BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT: Fig. 1.
Open Access
- 21 March 2006
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 34 (4), 724-726
- https://doi.org/10.1124/dmd.105.007658
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMESDrug Metabolism and Disposition, 2005
- THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIESDrug Metabolism and Disposition, 2004
- QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTESDrug Metabolism and Disposition, 2004
- THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2003
- The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical PropertiesDrug Metabolism and Disposition, 2002
- In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic ClearanceJournal of Pharmacology and Experimental Therapeutics, 2002
- Optimizing drug development: Strategies to assess drug metabolism/transporter interaction potential-toward a consensusClinical Pharmacology & Therapeutics, 2001